Cases
of mumps are forecast to scatter throughout the United States.
It’s not need for widespread panic although individuals with
the symptoms of mumps have already traveled outside the confines
of Iowa. While the vast majority of people infected with mumps
were vaccinated previously with a combined measles-mumps-rubella
(MMR) vaccine, the Center of Disease Control (CDC) recommends
two doses MMR vaccinations.
The CDC
advises one at 12 to 15 months of age, and the second vaccination
to happen from four to six years of age. Alternatively, the
vaccination is not 100-percent full-proof in the prevention
against the mump infection. For example, a single vaccination
dose is deemed 80 to 85-percent effective. A second dose elevates
increases the vaccination's efficacy to approximately 90 percent.
For
individuals unsure about the status of their mumps vaccination,
one more vaccine may serve as an ounce of prevention. Additionally,
patient may request blood examinations to evaluate the blood
for mump antibodies from a prior vaccination(s) or even exposure
to determine whether a vaccination is necessary.
From the
late 1980s to the early 1990s, the need for a second vaccination
against the mumps was recognized amongst health officials. Two
doses of the MMR vaccinations were recommended. From 12 to 15
months of age, the initial vaccination is prescribed. The second
dose is recommended from the age of four to six. The second
vaccination can occur at any age as long as it a minimum of
28 days subsequent to the initial dose.
The mumps
are a highly contagious viral infection that spreads ferociously
from one individual top the next through infected saliva. A
primary symptom includes painful swelling of the salivary glands,
predominantly the parotid glands. Other indications of the symptoms
are a cough, common cold symptoms, such as—fever, headache,
and muscle aches. |
